Domestic Self-Medication Operations
Domestic Self-Medication Operations
Meeting Your Health and Beauty Needs
Meeting Your Health and Beauty Needs
In Taisho Pharmaceutical Group's domestic self-medication business, we offer a range of health-related products, including OTC medicines available at drugstores and pharmacies, as well as health foods and cosmetics. We aim for sustainable growth by meeting the increasing health and beauty needs of consumers.
In Taisho Pharmaceutical Group's domestic self-medication business, we offer a range of health-related products, including OTC medicines available at drugstores and pharmacies, as well as health foods and cosmetics. We aim for sustainable growth by meeting the increasing health and beauty needs of consumers.
Outline of self-medication operations
Outline of self-medication operations
Responding to the needs of consumers, we offer a wide range of OTC medications.
Responding to the needs of consumers, we offer a wide range of OTC medications.
Our OTC medications, which are at the heart of our self-medication business, can be purchased without a prescription. Consumers can choose and buy these products themselves or consult with pharmacists at drugstores and pharmacies. So we strive to accurately understand the diverse needs of consumers and expand or renew our product portfolio accordingly, nurturing our brands. Currently, we lead the Japanese OTC market with over 40 brands, including the No.1 brand in its category.
Additionally, we focus on developing new products that meet consumer expectations for effectiveness. This includes "Switch OTC" products, which transition from prescription to OTC status, and "Direct OTC" products, which are approved directly as OTC medications without prior use as prescription drugs.
Our OTC medications, which are at the heart of our self-medication business, can be purchased without a prescription. Consumers can choose and buy these products themselves or consult with pharmacists at drugstores and pharmacies. So we strive to accurately understand the diverse needs of consumers and expand or renew our product portfolio accordingly, nurturing our brands. Currently, we lead the Japanese OTC market with over 40 brands, including the No.1 brand in its category.
Additionally, we focus on developing new products that meet consumer expectations for effectiveness. This includes "Switch OTC" products, which transition from prescription to OTC status, and "Direct OTC" products, which are approved directly as OTC medications without prior use as prescription drugs.
Pharmaceuticals, quasi-drugs, etc.
Pharmaceuticals, quasi-drugs, etc.
Lipovitan D
Lipovitan D
Pabron S Gold W microgranules
Pabron S Gold W microgranules
RiUP X5 Charge
RiUP X5 Charge
Shin Biofermin S tablets
Shin Biofermin S tablets
Vicks Medicated Drops
Vicks Medicated Drops
alli
alli
Expanding into New Areas Leveraging Our Pharmaceutical Expertise
Expanding into New Areas Leveraging Our Pharmaceutical Expertise
In response to the growing health needs in recent years, we leverage our expertise in pharmaceutical manufacturing to offer safe, high-quality, and high-performance health foods and cosmetics.
Additionally, to adapt to changes in consumer purchasing channels and enhance convenience, we are focusing on expanding our online sales channels, including "Taisho Pharmaceutical Direct" and "TAISHO BEAUTY ONLINE."
In response to the growing health needs in recent years, we leverage our expertise in pharmaceutical manufacturing to offer safe, high-quality, and high-performance health foods and cosmetics.
Additionally, to adapt to changes in consumer purchasing channels and enhance convenience, we are focusing on expanding our online sales channels, including "Taisho Pharmaceutical Direct" and "TAISHO BEAUTY ONLINE."
Health food (food with functional claims)
Health food (food with functional claims)
Premium Care powder stick
Premium Care powder stick
Anti-belly fat tablet PREMIUM
Anti-belly fat tablet PREMIUM
Anti-hypertension tablet (grain type)
Anti-hypertension tablet (grain type)
Beauty
Beauty
THE MYTOL ESSENCE
THE MYTOL ESSENCE
Alfe beauty conc <drink> W
Alfe beauty conc <drink> W
SHIROSAE wrinkle clear gel
SHIROSAE wrinkle clear gel
TOPIC：Japan's First Visceral Fat Reduction Medication "Alli" Launched
TOPIC：Japan's First Visceral Fat Reduction Medication "Alli" Launched
On April 8, 2024, the Taisho Pharmaceutical Group launched "Alli," Japan's first visceral fat reduction medication, designed for individuals with a larger abdominal area*. This medication is effective in reducing visceral fat and waist circumference, but only when combined with lifestyle improvements.
With the rise in lifestyle-related diseases due to changes in dietary habits, "Alli" was developed to meet the need for preventing diabetes and hypertension caused by excessive visceral fat accumulation.
Typically, dietary fats are broken down and absorbed by the enzyme lipase. However, when taking "Alli," the active ingredient orlistat binds to and inactivates lipase, preventing fat breakdown. As a result, some fats are excreted directly in the stool.
On April 8, 2024, the Taisho Pharmaceutical Group launched "Alli," Japan's first visceral fat reduction medication, designed for individuals with a larger abdominal area*. This medication is effective in reducing visceral fat and waist circumference, but only when combined with lifestyle improvements.
With the rise in lifestyle-related diseases due to changes in dietary habits, "Alli" was developed to meet the need for preventing diabetes and hypertension caused by excessive visceral fat accumulation.
Typically, dietary fats are broken down and absorbed by the enzyme lipase. However, when taking "Alli," the active ingredient orlistat binds to and inactivates lipase, preventing fat breakdown. As a result, some fats are excreted directly in the stool.
*Men with a waist circumference (at navel height) of 85 centimeters or larger and women with a waist circumference (at navel height) of 90 centimeters or larger.
*Men with a waist circumference (at navel height) of 85 centimeters or larger and women with a waist circumference (at navel height) of 90 centimeters or larger.
Alli, a visceral fat reducing drug
Alli, a visceral fat reducing drug
